Number of Shares
-
Current Holdings Value*
N/A
% of Portfolio
0%
Total Estimate Gain
$-2.87 Mil
% of Total Estimate Gain
-99.20%

Aisling Capital Management LP's Viracta Therapeutics Inc Holding Summary

As of 2025-03-31, Aisling Capital Management LP held - shares of Viracta Therapeutics Inc(VIRX), totaling N/A. This investment constitutes 0% of their stock portfolio, and Aisling Capital Management LP now holds 0% of the outstanding Viracta Therapeutics Inc(VIRX) stock.

The initial trade took place in 2021Q2. And since then Aisling Capital Management LP has made 1 purchases of VIRX, at an average price of $10.02, for a total of 288,571.00 shares. In addition, there have been 1 sales at an average price of $0.08 for 288,571.00 shares. Based on historical transaction data and VIRX's current price of $0.01, Aisling Capital Management LP's estimated gain on his VIRX holdings is $-2.87 Mil, reflecting a -99.20% gain to date.

Aisling Capital Management LP VIRX ($0.01) Holding Chart

Aisling Capital Management LP VIRX ($0.01) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price $-/Share
Shares Sold 0 Average Price $-/Share
Current Price $0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1